Akebia Therapeutics
AKBA
AKBA
124 hedge funds and large institutions have $58.3M invested in Akebia Therapeutics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10.52% less ownership
Funds ownership: 55.34% → 44.82% (-11%)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
73% less capital invested
Capital invested by funds: $218M → $58.3M (-$160M)
Holders
124
Holding in Top 10
1
Calls
$4.35M
Puts
$2.64M
Top Buyers
| 1 | +$838K | |
| 2 | +$508K | |
| 3 | +$273K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$242K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$206K |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$10.1M | |
| 3 | -$5.04M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.33M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.26M |